Moderna is now overvalued after cancer vaccine-led stock surge, Rothschild & Co. says
12 hours ago · CNBC
Global
& newspaper;
Read Full Article →
Sourced From
CNBC
The research firm downgraded the biotechnology stock to sell from neutral.
Source: CNBC — Read full article →
Content sourced from third parties. Copyright belongs to original publishers.
Source: CNBC — Read full article at source →
Content sourced from third parties. Copyright belongs to original publishers. Only excerpt and link are stored under fair use.